Needle-free value PIVO offers a needle-free blood collection solution that reduces pain and anxiety for patients while enhancing practitioner safety, presenting a compelling value proposition for hospital systems seeking to improve patient experience and staff welfare.

Adopted by leaders PIVO is already used across top U.S. hospital networks (Intermountain, Sutter, Northwestern, Henry Ford, etc.), signaling strong validation and a potential pathway for broader enterprise-wide deployments in large health systems.

Strategic acquisition Velano Vascular was acquired by BD in 2021, which can facilitate distribution, scale, and complementary product strategies, creating alignment opportunities for BD’s existing cardiovascular and diagnostics portfolios.

Growth and recognition The company has a track record of rapid growth and industry recognition (Fast Company Most Innovative Companies in 2020, Frost & Sullivan Product Leadership Award in 2019), highlighting a momentum angle for hospitals seeking innovative partnerships.

Training and rollout Recent initiatives include virtual training and implementation programs, which can ease enterprise onboarding and support rapid hospital adoption across complex procurement and IT ecosystems.